![[Podcast] Behind the Breakthroughs: How Almac Powers Clinical Trial Success with Care](https://imgproxy.divecdn.com/5lAJkli_KcGt1FSsw4EaegjgP76IHREqYEWbhNBJOXw/g:ce/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9CaW9QaGFybWFEaXZlXzEzNDZfeF83MjlfQXJ0d29yay5qcGc=.webp)
Second Legacy of Henrietta Lacks
This Viewpoint considers unjust enrichment stemming from the use of biospecimens known as offering particular value without informing the patient or gaining consent, as in the case of Henrietta Lacks.
This Viewpoint considers unjust enrichment stemming from the use of biospecimens known as offering particular value without informing the patient or gaining consent, as in the case of Henrietta Lacks.
